Citation Impact
Citing Papers
Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial
2014 Standout
Development of GPC2-directed chimeric antigen receptors using mRNA for pediatric brain tumors
2022 StandoutNobel
Bispecific antibodies for cancer therapy
2009
Pain Intensity on the First Day after Surgery
2013 Standout
Meta-analysis of the prognostic value of circulating tumor cells detected with the CellSearch System in colorectal cancer
2015
Laparoscopic Resection for Rectal Cancer: A Review
2009
Risk for postoperative infection after transfusion of white blood cell–filtered allogeneic or autologous blood components in orthopedic patients undergoing primary arthroplasty
2004
EpCAM an immunotherapeutic target for gastrointestinal malignancy: current experience and future challenges
2007
Colorectal Cancer Stem Cells: From the Crypt to the Clinic
2014
Targeting cancer-initiating cell drug-resistance: a roadmap to a new-generation of cancer therapies?
2011
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
2010 Standout
The ongoing variability in blood transfusion practices in cardiac surgery
2008
Current and future perspectives of liquid biopsies in genomics-driven oncology
2018 Standout
Delivery technologies for cancer immunotherapy
2019 Standout
Tumour-initiating cells: challenges and opportunities for anticancer drug discovery
2009
Colorectal cancer
2019 Standout
Antibody therapy of cancer
2012 Standout
Acute appendicitis: modern understanding of pathogenesis, diagnosis, and management
2015 Standout
Multicentric Study on Robotic Tumor-Specific Mesorectal Excision for the Treatment of Rectal Cancer
2010
Definition and grading of anastomotic leakage following anterior resection of the rectum: A proposal by the International Study Group of Rectal Cancer
2009 Standout
Controversies in Surgical Oncology: Does the Minimally Invasive Approach for Rectal Cancer Provide Equivalent Oncologic Outcomes Compared with the Open Approach?
2018
The cancer stem cell: premises, promises and challenges
2011 Standout
Paul Ehrlich's magic bullet concept: 100 years of progress
2008 Standout
Immunological Functions of the Omentum
2017 Standout
Bispecific antibodies for cancer therapy: A review
2017
Andrographolide and its analogues: versatile bioactive molecules for combating inflammation and cancer
2011 Standout
Development of therapeutic antibodies for the treatment of diseases
2020 Standout
Malignant ascites: A review of prognostic factors, pathophysiology and therapeutic measures
2012
The prognostic landscape of genes and infiltrating immune cells across human cancers
2015 Standout
The Emerging Role of In Vitro-Transcribed mRNA in Adoptive T Cell Immunotherapy
2019 StandoutNobel
Synthesis of Heterobifunctional Protein Fusions Using Copper‐Free Click Chemistry and the Aldehyde Tag
2012 StandoutNobel
Preoperative Iron Supplementation and Intraoperative Transfusion During Colorectal Cancer Surgery
2004
The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial
2010
The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY
2017 Standout
Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion
2016 Standout
2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines
2011 Standout
Clinical practice guidelines for antimicrobial prophylaxis in surgery
2013 Standout
Engineered Proteins Pull Double Duty
2010
Laparoscopic versus open surgery for suspected appendicitis
2018 Standout
Monoclonal Antibodies for Cancer Therapy
2012 StandoutNobel
Chromone: A Valid Scaffold in Medicinal Chemistry
2014 Standout
Intraperitoneal immunotherapy with T cells stably and transiently expressing anti-EpCAM CAR in xenograft models of peritoneal carcinomatosis
2017
International consensus statement on the peri‐operative management of anaemia and iron deficiency
2016 Standout
Synthesis of Heterobifunctional Protein Fusions Using Copper‐Free Click Chemistry and the Aldehyde Tag
2012 StandoutNobel
Prosthetic Joint Infection
2014 Standout
Guidelines for Perioperative Care in Elective Rectal/Pelvic Surgery: Enhanced Recovery After Surgery (ERAS®) Society Recommendations
2012 Standout
Intraperitoneal VEGF Inhibition Using Bevacizumab: A Potential Approach for the Symptomatic Treatment of Malignant Ascites?
2009
Pre-operative autologous donation for minimising perioperative allogeneic blood transfusion
2001
Effect of Robotic-Assisted vs Conventional Laparoscopic Surgery on Risk of Conversion to Open Laparotomy Among Patients Undergoing Resection for Rectal Cancer
2017 Standout
Nanobodies: Natural Single-Domain Antibodies
2013 Standout
Immunotherapy of cancer: from monoclonal to oligoclonal cocktails of anti‐cancer antibodies: IUPHAR Review 18
2016
Works of Michael A. Ströhlein being referenced
Induction of anti-tumor immunity by trifunctional antibodies in patients with peritoneal carcinomatosis
2009
Intraperitoneal immunotherapy to prevent peritoneal carcinomatosis in patients with advanced gastrointestinal malignancies
2009
Immunotherapy of malignant ascites with trifunctional antibodies
2005
Appendectomy in Germany—an analysis of a nationwide survey 2011/2012
2012
Immunotherapy of Peritoneal Carcinomatosis with the Antibody Catumaxomab in Colon, Gastric, or Pancreatic Cancer: An Open-Label, Multicenter, Phase I/II Trial
2011
MODULATION OF IMMUNE RESPONSE BY BLOOD TRANSFUSION: EVIDENCE FOR A DIFFERENTIAL EFFECT OF ALLOGENEIC AND AUTOLOGOUS BLOOD IN COLORECTAL CANCER SURGERY
1997
Comparison of Laparoscopic vs. Open Access Surgery in Patients with Rectal Cancer: A Prospective Analysis
2008
Effective Relief of Malignant Ascites in Patients with Advanced Ovarian Cancer by a Trifunctional Anti-EpCAM × Anti-CD3 Antibody: A Phase I/II Study
2007
Immunomonitoring Results of a Phase II/III Study of Malignant Ascites Patients Treated with the Trifunctional Antibody Catumaxomab (Anti-EpCAM × Anti-CD3)
2011